SAB Biotherapeutics Inc (SABSW)
NASDAQ
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -5.59 | -43.029 | -28.772 | -62.581 |
Return on Equity (%) | -112.5 | -88.913 | -53.847 | -95.508 |
Return on Invested Capital (%) | 8.219 | -87.422 | -93.829 | -86.966 |
Operating Margin (%) | N/A | -27.681 | -77.033 | -1870.433 |
Net Profit Margin (%) | N/A | -28.164 | -78.401 | -1884.502 |
Book Value Per Share | 0.006 | 0.886 | 0.722 | 1.095 |
Earnings Per Share | -0.003 | -0.394 | -0.436 | -0.806 |
Cash Per Share | 0.03 | 0.764 | 0.35 | 1.081 |
Working Capital Per Share | -0.076 | 0.546 | 0.165 | 0.919 |
Operating Profit Per Share | N/A | 1.4 | 0.556 | 0.043 |
EBIT Per Share | -0.003 | -0.394 | -0.435 | -0.806 |
EBITDA Per Share | -0.003 | -0.394 | -0.435 | -0.806 |
Free Cash Flow Per Share | -0.003 | -0.177 | -0.459 | -0.873 |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A |
Shares Outstanding | 2.88M | 43.49M | N/A | N/A |
Year End December 30 2023 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |||||
Shares Outstanding | 43.03M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | -1249.914 | N/A | N/A | N/A | -523.704 | N/A |
Net Profit Margin (%) | N/A | N/A | -1265.749 | N/A | N/A | N/A | -531.852 | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 3.82M |
Price to Earnings Ratio | -3.76 |
Price to Sales Ratio | 70.79 |
Price to Cash Ratio | 2.8 |
Price to Book Ratio | 2.77 |
Dividend Yield | - |
Shares Outstanding | 52.32M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.